Aytu BioPharma, Inc.AYTUNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank20
3Y CAGR-54.8%
5Y CAGR-41.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-54.8%/yr
vs +62.4%/yr prior
5Y CAGR
-41.7%/yr
Recent deceleration
Acceleration
-117.2pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $378000.00 | -71.5% |
| 2025 | $1.33M | -52.1% |
| 2024 | $2.77M | -32.4% |
| 2023 | $4.09M | -67.7% |
| 2022 | $12.66M | +125.2% |
| 2021 | $5.62M | +226.5% |
| 2020 | $1.72M | +192.3% |
| 2019 | $589072.00 | +251.5% |
| 2018 | $167595.00 | -87.6% |
| 2017 | $1.35M | - |